Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Crescent Capital BDC (FCRX) EBITDA Margin (2021 - 2025)

Historic EBITDA Margin for Crescent Capital BDC (FCRX) over the last 5 years, with Q3 2025 value amounting to 58.38%.

  • Crescent Capital BDC's EBITDA Margin fell 52400.0% to 58.38% in Q3 2025 from the same period last year, while for Sep 2025 it was 58.24%, marking a year-over-year decrease of 46300.0%. This contributed to the annual value of 54.1% for FY2024, which is 3600.0% up from last year.
  • Per Crescent Capital BDC's latest filing, its EBITDA Margin stood at 58.38% for Q3 2025, which was down 52400.0% from 59.79% recorded in Q2 2025.
  • Over the past 5 years, Crescent Capital BDC's EBITDA Margin peaked at 58.02% during Q2 2022, and registered a low of 326.48% during Q3 2021.
  • For the 5-year period, Crescent Capital BDC's EBITDA Margin averaged around 52.02%, with its median value being 54.47% (2023).
  • Its EBITDA Margin has fluctuated over the past 5 years, first surged by 3815100bps in 2022, then plummeted by -1132800bps in 2023.
  • Over the past 5 years, Crescent Capital BDC's EBITDA Margin (Quarter) stood at 326.48% in 2021, then surged by 114bps to 46.58% in 2022, then crashed by -215bps to 53.62% in 2023, then dropped by -4bps to 55.68% in 2024, then fell by -5bps to 58.38% in 2025.
  • Its EBITDA Margin was 58.38% in Q3 2025, compared to 59.79% in Q2 2025 and 59.36% in Q1 2025.